Cysteamine (Lynovex), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
Scientific Communications: pathophysiology 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy O - ESOC25-1367 EFFECT OF CEREBROLYSIN ON CIRCULATING TIGHT JUNCTION PROTEINS AFTER REPERFUSION THERAPY Sawomir Michalak 1 , Jacek Namysl 2 , Krystyna Osztynowicz 3 , Joanna Rybacka-Mossakowska 2 1 Poznan University of Medical Sciences, Department of Neurochemistry and Neuropathology, Stroke Unit University Hospital Poznan, Poznan, Poland, 2 Poznan University of Medical Sciences, Stroke Unit University Hospital Poznan, Poznan, Poland, 3 Poznan University of Medical Sciences, Poznan, Poland Background and Aims: Experimental studies revealed that Cerebrolysin affects the integrity of the blood-brain barrier (BBB)
KPV is not an FDA-approved drug
NAPQI further exacerbates this by binding to certain intracellular proteins, disrupting their functions and causing cellular damage (Ramachandran et al
